SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011439
Filing Date
2021-05-14
Accepted
2021-05-14 13:01:58
Documents
73
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 963396
2 ex10-1.htm EX-10.1 21057
3 ex10-2.htm EX-10.2 20927
4 ex31-1.htm EX-31.1 12412
5 ex31-2.htm EX-31.2 12973
6 ex32-1.htm EX-32.1 9419
  Complete submission text file 0001493152-21-011439.txt   4880331

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE qlgn-20210331.xml EX-101.INS 804102
8 XBRL SCHEMA FILE qlgn-20210331.xsd EX-101.SCH 60138
9 XBRL CALCULATION FILE qlgn-20210331_cal.xml EX-101.CAL 65970
10 XBRL DEFINITION FILE qlgn-20210331_def.xml EX-101.DEF 236685
11 XBRL LABEL FILE qlgn-20210331_lab.xml EX-101.LAB 400150
12 XBRL PRESENTATION FILE qlgn-20210331_pre.xml EX-101.PRE 321769
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 21923302
SIC: 2834 Pharmaceutical Preparations